BUSI 419 Week 8 Discussion Board Forum 8 Example

Discussion Board Forum 8: Outcomes, Cost-Effectiveness and Value in Health Care

BUSI 419 Management of Quality Improvement and Outcomes, Discussion Board Forum 8

Thread by [Student Name]

The hospital, its proposal and the classmates are composites; the textbook, Scripture and the peer-reviewed sources cited are real.

Our hospital's addiction medicine physicians have asked for a consultation team to see inpatients with opioid use disorder, most of whom are admitted for infections or injuries and leave without treatment for the underlying disorder. The finance committee asked a fair question: is it worth the money? Lighter (2011) explains that outcomes and cost must be considered together, because a program that improves results at an unreasonable cost and a program that saves money while harming patients both fail the test of value.

The best evidence comes from Okunogbe et al. (2026), who evaluated a hospital addiction consultation service tested in a randomized trial at three academic medical centers. The service cost about $640 per patient to run, mostly for staff, and patients who received it were more likely to start medication for opioid use disorder and to be linked to follow-up care. Compared with usual care, it cost about $162 more per patient and gained health at roughly $15,750 per quality-adjusted life year, well below the $150,000 threshold the authors used. In plain terms, the service buys a year of healthy life at about a tenth of what many payers consider acceptable.

That kind of value comes from changing care, not from rewarding or punishing results from a distance. Burke et al. (2025) evaluated Medicare's value-based purchasing program for skilled nursing facilities, which raises or lowers payments by up to 2% based on readmissions. Using data from 2011 to 2021, they found no effect on 30-day readmissions, mortality, length of stay or discharge to the community. A financial incentive alone did not change what happened to patients.

For our committee, the lesson is that money spent redesigning care, such as adding a consultation team that starts treatment at the bedside, is more likely to produce value than waiting for incentive payments to drive change. I recommended a one-year pilot with clear measures: treatment started before discharge, follow-up visits kept and readmissions within 30 days. Value is created where care is delivered, not where payments are calculated.

Jesus taught that much will be asked of the one entrusted with much (English Standard Version Bible, 2001/2016, Luke 12:48). Health care managers are entrusted with resources and with patients, and stewardship means spending on what demonstrably helps.

Reply to Simone

Simone, you raised a concern that quality-adjusted life years can seem to put a price on human life, and that they may undervalue people with disabilities or chronic illness. That concern is shared by many ethicists, and it deserves a serious answer. A quality-adjusted life year is a way of comparing how much health different programs produce for the same money, not a judgment of any person's worth. Still, because a year lived with a chronic condition may be weighted at less than a year in full health, programs that extend the lives of people with disabilities can appear less cost-effective than they are, and some policy makers have limited the use of such measures for that reason. Lighter (2011) treats cost-effectiveness as one input to decision support rather than the decision itself. Okunogbe et al. (2026) reported their result from a health sector perspective and a limited societal perspective, and the service looked favorable from both, which suggests the conclusion does not depend on a single assumption. A balanced approach would use cost per quality-adjusted life year to compare options while also reporting effects on equity, access and the groups most affected. For the addiction service, the people served are often among the most marginalized patients in the hospital, which strengthens rather than weakens the moral case. Do you think presenting both the cost-effectiveness numbers and the equity effects side by side would address your concern? Pairing the two would let leaders see efficiency and fairness at once instead of trading one for the other without noticing. It would also give clinicians and community members a way into the discussion, since equity effects are often easier to talk about than abstract ratios.

Reply to Marcus

Marcus, you argued that financial penalties are the most reliable way to get organizations to take quality seriously, since leaders pay attention to money. I agree that money gets attention, but evidence suggests attention does not always become improvement. Burke et al. (2025) found that Medicare's value-based purchasing program for skilled nursing facilities produced no measurable change in readmissions, mortality or length of stay over several years, even though facilities faced penalties of up to 2% of their Medicare payments. One reason may be that the incentive was small relative to other pressures, and another may be that many facilities lacked the staff or know-how to change their processes. Lighter (2011) emphasizes that improvement depends on understanding and redesigning processes, which a penalty does not supply on its own. Incentives may work better when they are large enough to matter, measure something the organization can actually influence and come with support such as data, training or improvement coaching. The contrast with Okunogbe et al. (2026) is instructive: their addiction service produced value because it changed what clinicians did at the bedside. If you were designing an incentive for your organization's units, what support would you pair with it so that managers had both the motivation and the means to improve? A modest bonus tied to one measure, plus an improvement coach for the units that need one, might accomplish more than a larger penalty applied without help, and it would show staff that leaders are invested in their success. Tracking whether the supported units improve faster than the others would also tell you, within a year, whether the support or the money was doing the work.

References

Burke, R. E., Hutchins, F., Heintz, J., Appel, S., Norman, J., Patel, S., Gupta, A., Rose, L., & Werner, R. M. (2025). Skilled nursing facility value-based purchasing failed to achieve hospital readmission reductions and other targets. Health Affairs, 44(6), 722-730. https://doi.org/10.1377/hlthaff.2024.01402

English Standard Version Bible. (2016). Crossway. (Original work published 2001)

Lighter, D. E. (2011). Advanced performance improvement in health care: Principles and methods. Jones and Bartlett Publishers.

Okunogbe, A., Peltz, A., Danovitch, I., Ober, A. J., & Nuckols, T. K. (2026). Cost-effectiveness of the START hospital addiction consultation service for opioid use disorder treatment. JAMA Network Open, 9(5), e2611324. https://doi.org/10.1001/jamanetworkopen.2026.11324